State-Targeted funding and technical assistance to increase access to medication treatment for opioid use disorder

Amanda J. Abraham, Christina M. Andrews, Colleen M. Grogan, Harold A. Pollack, Thomas D’Aunno, Keith Humphreys, Peter D. Friedmann

Research output: Contribution to journalArticle

Abstract

Objective: As the United States grapples with an opioid epidemic, expanding access to effective treatment for opioid use disorder is a major public health priority. Identifying effective policy tools that can be used to expand access to care is critically important. This article examines the relationship between state-targeted funding and technical assistance and adoption of three medications for treating opioid use disorder: oral naltrexone, injectable naltrexone, and buprenorphine. Methods: This study draws from the 2013–2014 wave of the National Drug Abuse Treatment System Survey, a nationally representative, longitudinal study of substance use disorder treatment programs. The sample includes data from 695 treatment programs (85.5% response rate) and representatives from single-state agencies in 49 States and Washington, D.C. (98% response rate). Logistic regression was used to examine the relationships of single-state agency targeted funding and technical assistance to availability of opioid use disorder medications among treatment programs. Results: State-targeted funding was associated with increased program-level adoption of oral naltrexone (adjusted odds ratio [AOR]=3.14, 95% confidence interval [CI]=1.49–6.60, p=.004) and buprenorphine (AOR=2.47, 95% CI=1.31–4.67, p=.006). Buprenorphine adoption was also correlated with state technical assistance to support medication provision (AOR=1.18, 95% CI=1.00–1.39, p=.049). Conclusions: State-targeted funding for medications May be a viable policy lever for increasing access to opioid use disorder medications. Given the historically low rates of opioid use disorder medication adoption in treatment programs, single-state agency targeted funding is a potentially important tool to reduce mortality and morbidity associated with opioid disorders and misuse.

Original languageEnglish (US)
Pages (from-to)448-455
Number of pages8
JournalPsychiatric Services
Volume69
Issue number4
DOIs
StatePublished - Apr 1 2018

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'State-Targeted funding and technical assistance to increase access to medication treatment for opioid use disorder'. Together they form a unique fingerprint.

  • Cite this